Statement Of Financial Position [Abstract]

Mithra Pharmaceuticals S.A. - Filing #3183198

Concept	As at 2021-12-31	As at 2021-12-31	As at 2021-12-31	As at 2021-12-31	As at 2021-12-31	As at 2020-12-31	As at 2020-12-31	As at 2020-12-31	As at 2020-12-31	As at 2020-12-31	As at 2019-12-31	As at 2019-12-31	As at 2019-12-31	As at 2019-12-31	As at 2019-12-31
Statement of financial position [abstract]
Assets [abstract]
Property, plant and equipment	38,354,000 EUR	—	—	—	—	29,921,000 EUR	—	—	—	—	—	—	—	—	—
Right-of-use assets	69,322,000 EUR	—	—	—	—	69,572,000 EUR	—	—	—	—	—	—	—	—	—
Goodwill	5,233,000 EUR	—	—	—	—	5,233,000 EUR	—	—	—	—	—	—	—	—	—
Intangible assets other than goodwill	104,954,000 EUR	—	—	—	—	89,005,000 EUR	—	—	—	—	—	—	—	—	—
Deferred tax assets	63,456,000 EUR	—	—	—	—	50,905,000 EUR	—	—	—	—	—	—	—	—	—
Cash and cash equivalents	32,872,000 EUR	—	—	—	—	138,675,000 EUR	—	—	—	—	—	—	49,720,000 EUR	—	—
Assets	421,918,000 EUR	—	—	—	—	521,985,000 EUR	—	—	—	—	—	—	—	—	—
Equity and liabilities [abstract]
Equity [abstract]
Issued capital	32,250,000 EUR	—	—	—	—	31,271,000 EUR	—	—	—	—	—	—	—	—	—
Retained earnings	336,633,000 EUR	—	—	—	—	219,759,000 EUR	—	—	—	—	—	—	—	—	—
Other reserves	2,545,000 EUR	—	—	—	—	13,690,000 EUR	—	—	—	—	—	—	—	—	—
Equity	33,840,000 EUR	336,634,000 EUR	2,545,000 EUR	340,769,000 EUR	32,250,000 EUR	157,737,000 EUR	31,271,000 EUR	219,759,000 EUR	332,535,000 EUR	13,690,000 EUR	127,673,000 EUR	3,423,000 EUR	163,298,000 EUR	258,898,000 EUR	28,649,000 EUR
Liabilities [abstract]
Deferred tax liabilities	6,089,000 EUR	—	—	—	—	4,363,000 EUR	—	—	—	—	—	—	—	—	—
Equity and liabilities	421,918,000 EUR	—	—	—	—	521,985,000 EUR	—	—	—	—	—	—	—	—	—